Please login to the form below

Not currently logged in
Email:
Password:

IMS Health

This page shows the latest IMS Health news and features for those working in and with pharma, biotech and healthcare.

INC Research to merge with InVentiv Health

INC Research to merge with InVentiv Health

INC Research to merge with InVentiv Health. Combined will be second-largest outsourcing provider after QuintilesIMS.

Latest news

  • Xarelto beats aspirin for recurrent blood clots Xarelto beats aspirin for recurrent blood clots

    The results could therefore provide a boost to the position in the NOAC market held by Xarelto, which according to IMS Health figures had 46.5% of the market ahead of

  • ICON boosts leadership teams ICON boosts leadership teams

    Carroll has over 20 years of CRO and pharmaceutical experience, and joins ICON from inVentiv Health where he led its real world data (RWD)-driven service unit. ... Previously, Carroll oversaw IMS Health's RWD analytic solutions offering, helping to

  • IMS Health and Quintiles complete merger IMS Health and Quintiles complete merger

    IMS Health and Quintiles complete merger. Launch global healthcare information and technology specialist QuintilesIMS. ... IMS Health and Quintiles have completed their merger to transform the two firms into a single, information and technology-led

  • Diabetes treatment 'inextricably' linked to patient education Diabetes treatment 'inextricably' linked to patient education

    Diabetes treatment 'inextricably' linked to patient education. Condition remains a significant burden for health systems. ... The issue is not so much in diagnosis and treatment options, both of which have improved, says IMS.

  • The Digital Patient The Digital Patient

    IMS Health reported that there are escalating numbers of health apps – more than 165, 000 at last count – with 1 in 10 of them using a smartphone or some other device ... Overall, there seems little doubt that Europeans are willing to embrace digital

More from news
Approximately 15 fully matching, plus 98 partially matching documents found.

Latest Intelligence

  • A digital strategy in a digital world A digital strategy in a digital world

    Across Health's 2016 survey of 275 marketeers from these industries (94% pharma) found that nearly 60% of respondents reported that the digital transformation of their organisation was moving very slowly. ... A study by IMS Health published in PME in

  • Transformational technology Transformational technology

    To examine the impact of these and other digital health trends, IMS Health and Egon Zehnder, in association with PME, convened a CIO roundtable meeting in London in March - Transforming Technology ... It is a very common idea now that pharma needs to

  • Why multichannel is not an in/out option Why multichannel is not an in/out option

    A recent IMS Health White Paper - The Essential European Revolution - outlined why multichannel is vital to pharma in Europe, but warned that the region is lagging behind the US and Japan ... However, while digital interaction in the US and Japan is

  • Multichannel: the essential European revolution Multichannel: the essential European revolution

    Sarah Rickwood is VP, European thought leadership, IMS Health, . In association with . 12th August 2016.

  • Deal Watch May 2016 Deal Watch May 2016

    Doing the complete opposite and consolidating, Quintiles and IMS Health announced the merger of their respective businesses to form a mega-CRO with a combined market capitalisation of $17.6bn. ... 293. OPKO Health/ Vifor Fresenius. Licence. Rayaldee in EP

More from intelligence
Approximately 3 fully matching, plus 20 partially matching documents found.

Latest appointments

  • Medmeme bolsters its sales team Medmeme bolsters its sales team

    organisations.”. Barbalinardo has also held roles for Aileron Solutions – which was acquired by IMS Health in 2014 -, Within3, and Pfizer.

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... Jones previously worked for a variety of biotech, pharma and service companies

  • Helen Parfitt joins Research Partnership Helen Parfitt joins Research Partnership

    Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director

  • GPI appoints commercial director GPI appoints commercial director

    Stewart joins the pharmaceutical and biotech pricing solutions firm from IMS Health, where he served as a global pricing solution specialist.

  • Wilmington Healthcare appoints managing director Wilmington Healthcare appoints managing director

    Previously, Thomas served as international development director for Doctors.net.uk - part of the M3 Group - and was responsible for setting up global physician online community alliance Networks in Health. ... He also brings experience from

More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • What does social media listening actually tell us?

    And in response to the suggestion that social media users don’ t represent the ‘ average’ patients, in a survey conducted by Novartis and IMS Health on MS patients, 10, 000 pharma

  • Dissecting adherence to personalise patient support

    According to the IMS Institute for Healthcare Informatics, activating patients can solve non-adherence. ... Philipson, T. (2015). Non-Adherence in Health Care: Are Patients Or Policy Makers Ill-Informed?

  • NEW SENIOR CONSULTANT FOR CELLO HEALTH CONSULTING

    Rob brings 20 years’ marketing experience, including roles as Strategic Marketing Director at IMS Health; Director, Marketing and Sales Operations at NextPharma Technologies; and as a Business Strategy Consultant at Moorfields ... Rob will be based at

  • TWO SENIOR APPOINTMENTS FOR CELLO HEALTH BIOCONSULTING

    Mark Kasakevich has over 20 years experience in healthcare and consulting at Bayer, IMS Health and Campbell Alliance. ... Philip and Mark will be based at Cello Health’ s BioConsulting Philadelphia office. -

  • Therapy Watch appoints new Associate Director

    Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA (IMS Health), where he led field work, analytics, forecasting and report writing for

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics